Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, have produced the first end-to-end DNA sequence of a human chromosome.

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

Researchers from the Terasaki Institute for Biomedical Innovation have identified that type 5 collagen regulates the size of scar tissue formed after injury to the heart.

Researchers are using sequencing technologies to rapidly expand our knowledge of the human microbiome and identify undiscovered bacterial genomes.

In the first of our exclusive three-part interview series with Blue Brain Project Founder and Director Professor Henry Markram, we discuss the basics of simulation neuroscience. Markram, one of the leading proponents of the field, comments on why the idea of simulating the brain has raised concerns from experimental and theoretical neuroscientists and answers whether in silico techniques could ultimately replace experimental approaches.

In this article, we explore recent developments related to cell-based phenotypic screening, discuss the elements of a good phenotypic drug screen, and discover how these approaches are helping to provide a more accurate biological context for drug screening.